Diet and asthma: Has the role of dietary lipids been overlooked in the management of asthma?

Annals of Allergy, Asthma and Immunology

Volumn 90, Issue 4, 2003, Pages

  Spector, Sheldon L ^a,d   Surette, Marc E ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ LAVAL   (Canada)

^c Pilot Therapeutics Inc   (United States)

^d California Allerg/Asthma Med Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LIPID; OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID;

ASTHMA; BODY MASS; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIET; DIETARY INTAKE; DISEASE SEVERITY; FAT INTAKE; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; LANGUAGE; LIPOGENESIS; MEDIATOR; MEDLINE; NUTRIENT; OBESITY; PATHOPHYSIOLOGY; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; REVIEW; TH2 CELL;

EID: 0344837753     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)61817-0     Document Type: Review

References (49)

1. Kay AB. Allergy and allergic diseases. N Engl J Med 2001; 344:30-36.
2. Greene LS. Asthma, oxidant stress, and diet. Nutrition 1999;15: 899-907.
3. Kuo ML, Huang JL, Yeh KW, et al. Evaluation of Th1/Th2 ratio and cytokine production profile during acute exacerbation and convalescence in asthmatic children. Ann Allergy Asthma Immunol 2001;86:272-276.
4. Diaz-Sanchez D, Penichet-Garcia M, Saxon A. Diesel exhaust particles directly induce activated mast cells to degranulate and increase histamine levels and symptom severity. J Allergy Clin Immunol 2000;106:1140-1146.
5. Stenius-Aarniala B, Poussa T, Kvarnström J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000;320:827-832.
6. Broughton KS, Johnson CS, Pace BK, et al. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997;65:1011-1017.
7. Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Respir J 1997;10:6-12.
8. Kelley DS. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 2001;17:669-673.
9. Villani F, Comazzi R, De Maria P, Galimberti M. Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyperreactivity in subjects with seasonal asthma. Respiration 1998;65:265-269.
10. 4 production by blood neutrophils in allergic rhinitis-effects of cetirizine. Clin Exp Allergy 1995;25:729-736.
11. 4 levels from stimulated neutrophils from healthy and allergic subjects: effect of platelets and exogenous arachidonic acid. Eur J Clin Invest 1991;21:631-637.
12. Kohi F, Miyagawa H, Agrawal DK, et al. Generation of leukotriene B4 and C4 from granulocytes of normal controls, allergic rhinitis, and asthmatic subjects. Ann Allergy 1990;65:228-232.
13. Pacheco Y, Hosni R, Chabannes B, et al. Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of β2 agonist therapy. Eur J Clin Invest 1992;22:732-739.
14. Radeau T, Chavis C, Damon M, et al. Enhanced arachidonic acid metabolism and human neutrophil migration in asthma. Prostaglandins Leukot Essent Fatty Acids 1990;41:131-138.
15. Radeau T, Chavis C, Godard PH, et al. Arachidonate 5-lipoxygenase metabolism in human neutrophils from patients with asthma: in vitro effect of nedocromil sodium. Int Arch Allergy Immunol 1992;97:205-215.
16. Sampson AP, Thomas RU, Costello JF, Piper PJ. Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol 1992;33:423-430.
17. Sampson AP, Evans JM, Garland LG, et al. The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects. Pulm Pharmacol 1990;3: 111-119.
18. 4 production by peripheral eosinophilic granulocytes from children with asthma. Int Arch Allergy Appl Immunol 1989;90: 201-206.
19. 4 release in stimulated asthmatic neutrophils by platelet activating factor. Thorax 1997;52:1024-1029.
20. National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997: Publication no 97-4051.
21. National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma - Update of Selected Topics 2002. Bethesda, MD: National Institutes of Health; 2002: Publication no 02-5075.
22. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
23. Spector SL. Leukotriene activity modulation in asthma. Drugs 1997;54:369-384.
24. Spector SL. Use of antileukotriene agents in asthma management. Comp Ther 2000;26:31-38.
25. Baker JC, Ayres JG. Diet and asthma. Respir Med 2000;94: 925-934.
26. Seidell JC, Flegal KM. Assessing obesity: classification and epidemiology. Br Med Bull 1997;53:238-252.
27. Camargo CA Jr, Weiss ST, Zhang S, et al. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999;159:2582-2588.
28. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and long volumes in obese patients with asthma. Chest 2000;118: 1315-1321.
29. Israel E, Rubin P, Kemp JP, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993;119:1059-1066.
30. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217-1224.
31. Weiland SK, von Mutius E, Husing A, Asher MI. Intake of trans fatty acids and prevalence of childhood asthma and allergies in Europe. ISAAC Steering Committee. Lancet 1999;353: 2040-2041.
32. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71(Suppl):343S-348S.
33. Kinsella JE, Lokesh B, Stone RA. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 1990;52:1-28.
34. Arm JP, Horton CE, Mencia-Huerta JM, et al. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988;43:84-92.
35. Chilton FH, Patel M, Fonteh AN, et al. Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. J Clin Invest 1993;91: 115-122.
36. Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991;95:156-157.
37. Arm JP, Horton CE, Spur BW, et al. The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989; 139:1395-1400.
38. Thien FC, Mencia-Huerta JM, Lee TH. Dietary fish oil effects on seasonal hay fever and asthma in pollen sensitive subjects. Am Rev Respir Dis 1993;147:1138-1143.
39. Kirsch CM, Payan DG, Wong MY, et al. Effect of eicosapentaenoic acid in asthma. Clin Allergy 1988;18:177-187.
40. Hodge L, Salome CM, Hughes JM, et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998;11:361-365.
41. Nagakura T, Matsuda S, Shichijyo K, et al. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000;16: 861-865.
42. Fan YY, Chapkin RS. Importance of dietary γ-linolenic acid in human health and nutrition. J Nutr 1998;128:1411-1414.
43. Chilton-Lopez T, Surette ME, Swan DD, et al. Metabolism of gammalinolenic acid in human neutrophils. J Immunol 1996; 156:2941-2947.
44. Chapkin RS, Miller CC, Somers SD, Erickson KL. Utilization of dihomo-γ-linolenic acid (8,11,14-eicosatrienoic acid) by murine peritoneal macrophages. Biochim Biophys Acta 1988;959: 322-331.
45. Chapkin RS, Miller CC, Somers SD, Erickson KL. Ability of 15-hydroxyeicosatrienoic acid (15-OH-20:3) to modulate macrophage arachidonic acid metabolism. Biochem Biophys Res Commun 1988;153:799-804.
46. Johnson MM, Swan DD, Surette ME, et al. Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutri 1997;127: 1435-1444.
47. Barham JB, Edens MB, Fonteh AN, et al. Addition of eicosapentaenoic acid to γ-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr 2000; 130:1925-1931.
48. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 1999;27:1409-1420.
49. Bowton DL, Seeds M, Surette ME, et al. Airozin suppresses leukotriene synthesis in asthmatics. Am J Respir Crit Care Med 2002;165:A95.